KASSANDRA PRICE: Open Payments
NPI 1538814702 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,341 in 194 payments from 24 companies in 2025. Trend: 2023 $2,049 · 2024 $3,623 · 2025 $5,341
Food & beverage: $4,742Consulting: $500Education: $99
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 17 | $1,041 |
| UCB, Inc. | 18 | $511 |
| Lilly USA, LLC | 12 | $441 |
| Botanix SB Inc | 7 | $361 |
| PFIZER INC. | 17 | $356 |
| GENZYME CORPORATION | 9 | $342 |
| Regeneron Healthcare Solutions, Inc. | 17 | $332 |
| Organon LLC | 7 | $306 |
| Galderma Laboratories, L.P. | 20 | $286 |
| ABBVIE INC. | 17 | $263 |
Products named: Zoryve, DUPIXENT, Bimzelx, EBGLYSS, SOFDRA, CIBINQO, VTAMA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
